Opendata, web and dolomites

His-Li mouse

His-Li mouse, the unique humanized mouse model resembling human liver and immune systems

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 His-Li mouse project word cloud

Explore the words cloud of the His-Li mouse project. It provides you a very rough idea of what is the project "His-Li mouse" about.

evaluation    trials    service    benefit    drugs    quality    discovery    absorption    total    sound    millions    excretion    human    eliminate    clinical    experimental    reveal    programs    lives    physiology    bioservices    critical    unexpected    fail    models    representing    potentially    validation    feasibility    toxic    save    chain    li    fact    generation    offers    immune    21    humanized    market    mouse    adme    tests    protocol    transcure    customers    reduce    metabolism    breakthrough    70    perfectly    costly    safe    iterations    accurate    approved    first    pharmaceuticals    safety    unpredictably    combination    reflect    efficacy    subsequently    perform    toxicology    model    pharmaceutical    deadly    humanization    drug    strikingly    plans    lies    global    validate    liver    rate    toxicity    reflects    tool          efficient    single    unnecessary    lack    13    reaching    least    faster    humans    accounting    optimise    population    prospect    strategy    innovation    mice    supply    preclinical   

Project "His-Li mouse" data sheet

The following table provides information about the project.

Coordinator
TRANSCURE BIOSERVICES SAS 

Organization address
address: BIOPARK LE FORUM 1 260 AVENUE MARI
city: ARACHAMPS
postcode: 74160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.transcurebioservices.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TRANSCURE BIOSERVICES SAS FR (ARACHAMPS) coordinator 50˙000.00

Map

 Project objective

Preclinical toxicology evaluation is the most critical step in pharmaceutical drug development, representing about 21.2% of the total drug development costs. About 70% of drug development programs fail due to toxicity or unexpected issues in Absorption, Distribution, Metabolism, and Excretion (ADME) at Phase 1 validation on humans. The main problem lies on the lack of accurate and reliable pre-clinical mouse models: in fact, current models fail to reflect human liver physiology, and often lead to the development of drugs that are safe in mice, and reveal unpredictably toxic or even deadly in humans. Strikingly, only 13.8% of drugs development programs are finally approved. The development of a single drug requires at least 1,000 iterations, accounting for about €10 M in total, and procedures that can take up to 10 years. TransCure bioServices offers the His-Li-mouse, a humanized mouse model for pre-clinical drug testing, based on the unique combination of the humanized liver and immune systems. His-Li-mouse is the first pre-clinical model that perfectly reflects the human liver physiology and immune response, thus representing a unique tool to perform reliable pre-clinical safety and efficacy tests of drugs. His-Li-mouse enables to reduce the failure rate observed when reaching the clinical trials and to subsequently eliminate unnecessary and costly experimental iterations. This will benefit to the global population, as a more efficient drug development process will potentially save millions of lives or improve its quality by enabling the faster discovery of breakthrough pharmaceuticals. During the phase 1 feasibility study, TransCure will establish a sound go-to-market strategy and supply chain, and will draft further development plans. During the innovation project, TransCure will optimise the humanization protocol, scale-up mice generation and validate the His-Li-mouse pre-clinical service with prospect customers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HIS-LI MOUSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HIS-LI MOUSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

Path Feel (2019)

Insoles for Neuropathy and Balance Issues

Read More